AuntMinnieEurope

The European Parliament in Brussels approved the EU AI Act in 2024, establishing a risk-based regulatory framework for artificial intelligence, including high-risk medical AI systems.

EU AI Act brings radiology AI oversight into daily practice

A new opinion paper calls on European imaging departments to strengthen AI auditing and monitoring in patient care.

Featured

Illustration of musculoskeletal x-ray imaging. New European guidance aims to harmonize imaging protocols for osteosarcoma and Ewing sarcoma.

European guideline aims to harmonize bone sarcoma imaging

Adobe Stock 517622853

CT reveals severe craniofacial, ocular trauma from pager blasts

F-18 PI-2620 average binding potential maps. Mean tracer binding (DVR) image from 165 older adults (A) and 13 young adults (B). Images are scaled from 1 to 1.8 for display purposes, but DVR values of less than 1 were frequently observed.

Tau PET tracer flags early Alzheimer risk in healthy older adults

July 17, 2026

Top eight incorrectly classified synthetic images (Most convincing fake images). Images A, B, C, D, E, F, G and H were the most infrequently correctly classified images at 24%, 43%, 59%, 64%, 69%, 71%, 71% and 73% respectively. All images are AI-generated. Images A, B and C are head CTs. Images D and E are chest CTs. Image F is a cardiac CT. Image G is a musculoskeletal MRI. Image H is a head MRI. Images are republished under a Creative Commons license (CC BY 4.0).

Radiologists can identify three out of four AI-generated images

July 17, 2026

Prostate Cancer 400

MRI could replace DRE for prostate cancer staging

July 15, 2026

A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.

Incorrect AI suggestions influence reader performance on mammography

July 14, 2026

Check out our Cases of the Week!

68-year-old woman with elevated calcium, parathyroid hormone revisited

A 68-year-old woman presented with elevated ionized calcium level of 6.1 mg/dL and elevated parathyroid hormone (PTH) level of 158 pg/mL.

60-year-old man with penile and scrotal swelling revisited

32-year-old man with subacute left jaw pain revisited

Illustration of musculoskeletal x-ray imaging. New European guidance aims to harmonize imaging protocols for osteosarcoma and Ewing sarcoma.

European guideline aims to harmonize bone sarcoma imaging

CT reveals severe craniofacial, ocular trauma from pager blasts

Tau PET tracer flags early Alzheimer risk in healthy older adults

MRI could replace DRE for prostate cancer staging

Incorrect AI suggestions influence reader performance on mammography

The European Parliament in Brussels approved the EU AI Act in 2024, establishing a risk-based regulatory framework for artificial intelligence, including high-risk medical AI systems.

EU AI Act brings radiology AI oversight into daily practice

Radiologists can identify three out of four AI-generated images

The cost of AI, and finding its breakeven point

AI aims to decode targeted radiotherapy response

RCR: Agentic AI is off the leash, and already a workhorse for health systems

Veriton CT 400 Series digital SPECT/CT scanner with all-energy enhancement.

Spectrum Dynamics expands Veriton SPECT/CT line

CryoTherapeutics treats first patient in ICECAP coronary plaque trial

Siemens to invest €70 million to expand site in Germany

Actineer completes Ra-226 recycling process to support Ac-225 supply

HistoSonics gets CE Mark for histotripsy system

Spectrum Dynamics expands Veriton SPECT/CT line

By AuntMinnie.com staff writers

The company has unveiled an all-energy enhancement for its CT-400 series digital SPECT/CT scanner.

July 20, 2026

Veriton CT 400 Series digital SPECT/CT scanner with all-energy enhancement.

CryoTherapeutics treats first patient in ICECAP coronary plaque trial

By AuntMinnieEurope.com staff writers

The trial is evaluating localized cryotherapy for stabilizing high-risk non-obstructive coronary plaques.

July 16, 2026

Heart Pulmonary Trunk 400

Siemens to invest €70 million to expand site in Germany

By AuntMinnieEurope.com staff writers

The hall will have a total floor area of about 4,500 square meters, including 3,400 square meters of production space for radiotherapy components.

July 15, 2026

Large Korean study adds evidence on contrast media hypersensitivity

By Claudia Tschabuschnig

A Korean study of almost 116,000 contrast media recipients adds new evidence on hypersensitivity risk factors, but a European expert says the findings should be interpreted in the context of current European practice.

July 14, 2026

Iodinated contrast media are among the most commonly administered agents in radiology.

Actineer completes Ra-226 recycling process to support Ac-225 supply

By AuntMinnie.com staff writers

This process aims to improve Ac-225 supply predictability and cost stability, as well as reduce waste generation.

July 14, 2026

Nuclear Medicine Worker Sm

MRI shows higher neuro symptom burden for former football players

By Amerigo Allegretto

Former elite football players have lower white matter volume and report higher levels of depression and anxiety.

July 13, 2026

Voxel-based morphometry (VBM) group comparison of grey matter brain volumes. TFCE-corrected significance map shown (one-tailed t-test; higher significance indicated by light blue color). (a) Comparison between ex-soccer players (n = 124) and controls (n = 40). (b) Comparison between ex-rugby players (n = 200) and controls (n = 33) from Graham & Zimmerman et al. (2025), reproduced with permission under Creative Commons license.

German registry shows sharp rise in carotid artery stenting as CREST-2 reshapes prevention

By Claudia Tschabuschnig

German hospitals performed a record 5,623 carotid artery stenting procedures in 2025, with new registry data and findings from the CREST-2 trial highlighting the evolving management of asymptomatic carotid stenosis.

July 13, 2026

Surgeon performs a carotid artery procedure.

HistoSonics gets CE Mark for histotripsy system

By AuntMinnie.com staff writers

The system uses histotripsy, a noninvasive focused ultrasound technology that mechanically destroys liver tumors without surgery, needles, radiation, or heat.

July 13, 2026

Histosonics System (2) (1) (1)

CEM on par with MRI for breast cancer diagnosis, local staging

By Amerigo Allegretto

CEM alone in a prospective study achieved perfect sensitivity and negative predictive value in diagnosing breast cancer.

July 10, 2026

MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).

New PET tracer show promise in neuroblastoma

F-18 mFBG achieved a pooled sensitivity of 97%, compared with 82% for I-123 MIBG.

July 9, 2026

The cost of AI, and finding its breakeven point

By Claudia Tschabuschnig

Who pays, what, where, and when: speakers at the Royal College of Radiologists' Global AI Conference dug into what AI actually costs and when, if ever, it pays for itself.

July 9, 2026

Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.

Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial

By AuntMinnie.com staff writers

The study is evaluating an investigational alpha-emitting PSMA-targeted radiopharmaceutical in prostate cancer patients.

July 9, 2026